The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 08, 2022
Filed:
Apr. 04, 2019
Applicant:
Epitech Group S.p.a., Milan, IT;
Inventors:
Maria Federica Della Valle, Milan, IT;
Francesco Della Valle, Milan, IT;
Vincenzo Di Marzo, Milan, IT;
Stefania Petrosino, Milan, IT;
Barbara Costa, Milan, IT;
Gabriele Marcolongo, Milan, IT;
Daniele Grassi, Milan, IT;
Assignee:
Epitech Group S.p.A., Milan, IT;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/16 (2006.01); A61K 45/06 (2006.01); A61K 31/164 (2006.01); A61K 31/201 (2006.01); A61K 31/421 (2006.01); A61K 31/728 (2006.01); A61K 36/062 (2006.01); A61K 36/28 (2006.01);
U.S. Cl.
CPC ...
A61K 31/16 (2013.01); A61K 31/164 (2013.01); A61K 31/201 (2013.01); A61K 31/421 (2013.01); A61K 31/728 (2013.01); A61K 36/062 (2013.01); A61K 36/28 (2013.01); A61K 45/06 (2013.01);
Abstract
Described herein is the use of Adelmidrol in the treatment of epithelial dysfunctions. In particular, described herein is Adelmidrol for use in the treatment of epithelial tissue dysfunctions in a human being or animal, wherein said Adelmidrol causes an increase of the endogenous levels of Palmitoylethanolamide without inhibiting the activity of the Palmitoylethanolamide-degrading FAAH and NAAA enzymes.